DERMABOND™ PRINEO™ Skin Closure System
DERMABOND™ PRINEO™ Skin Closure System
DERMABOND PRINEO System combines the proven strength, flexibility, and microbial barrier of DERMABOND ADVANCED™ with the security of a self-adhering mesh to facilitate skin closure and an optimal healing environment.1-6*
IMAGES
Features & Benefits
Simplified at-home care
With its transparent barrier that allows for observation of the incision, DERMABOND PRINEO System may be especially suitable for surgeons who have adopted telemedicine protocols in their post-op care. Patients may be able to shower immediately after their procedure, if directed by the healthcare professional.4
Microbial barrier
DERMABOND PRINEO System creates a watertight seal ,creating a barrier to water and bacteria entering the wound.4,7 Furthermore, the microbial barrier protection of DERMABOND PRINEO System is proven 99% effective through 72 hours in vitro.8†
Elevate team performance
Whether it's sharpening skills or making life easier finding efficiencies in the OR, our education programs can help you take your wound closure to the next level.
Supporting Documentation
Clinical Evidence
-
DERMABOND PRINEO Evidence Brief
-
PRINEO C-Section Study Stat
-
Spine Evidence
-
Cardiovascular Evidence
-
Multi Layer Watertight Closure Study
-
DERMABOND PRINEO FAQ
-
C-Section Value Brief
-
Dr. Snyder/TriHealth Case Study
-
PRINEO Dermatitis Study Stat
-
Select all documents (9)
Wound Closure Procedures
References
*As demonstrated in vitro.
†Clinical significance unknown.
‡In an ex-vivo study, more load in N was required to create a 3 ±1 mm gap between skin edges approximated with DERMABOND PRINEO System, than with subcuticular 4-0 MONOCRYL Suture or PROXIMATE® Ethicon Endo-Surgery skin staples (P=0.00).
1. Keplinger S. Protocol investigation of the comparison of PRINEO with conventional wound closure techniques. 07PD048. May 2007. Ethicon, Inc.
2. Richter D. Multi-centre study to show equivalence of DERMABOND PROTAPE to INTRADERMAL SUTURES for skin closure of full thickness surgical incisions associated with breast procedures. 07CS003. Final Report 09 July 2010. Ethicon, Inc.
3. Richter D. Multi-centre study to show equivalence of DERMABOND PROTAPE to INTRADERMAL SUTURES for skin closure of full thickness surgical incisions. 06CS005. Final Report 10 June 2010. Ethicon, Inc.
4. DERMABOND® PRINEO® Skin Closure System (22 cm), Instructions for Use. Ethicon, Inc.
5. Shapiro AJ, Dinsmore RC, North JH, Tensile strength of wound closure with cyanoacrylate glue. Am Surg. 2001;67:1113-1115.
6. Kannon GA, Garrett AB. Moist wound healing with occlusive dressings. Dermatol Surg. 1995;21:583-590.
7. Kumar A. Completion Report for Design Verification testing for DERMABOND PRINEO 22cm skin closure system (DP22) AST-2014-0060 Version 2. April 19, 2016. Ethicon, Inc.
8. Su W. Study Report for in vitro evaluation of microbial barrier properties of DERMABOND ProTape. Report Number 06TR071. December 4, 2006. Ethicon, Inc.
9. Kumar A. Study to Compare the tissue holding strength of PRINEO™ skin closure system with conventional wound closure techniques. AST-2012-0290. 2012. Ethicon, Inc.
© Ethicon US, LLC. 2022.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.
